Works matching IS 13866346 AND DT 2024 AND VI 54 AND IP 7

Results: 10

Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real‐world multicenter cohort study.

Published in:

Hepatology Research, 2024, v. 54, n. 7, p. 627, doi. 10.1111/hepr.14021

By:

Shin, Hyunjae;
Kim, Seung Up;
Song, Byeong Geun;
Park, Youngsu;
Ko, Yunmi;
Park, Jeayeon;
Hur, Moon Haeng;
Lee, Yun Bin;
Cho, Eun Ju;
Lee, Jeong‐Hoon;
Yu, Su Jong;
Yoon, Jung‐Hwan;
Sinn, Dong Hyun;
Kim, Yoon Jun

Publication type:

Article

Profiles associated with significant hepatic fibrosis consisting of alanine aminotransferase >30 U/L, exercise habits, and metabolic dysfunction‐associated steatotic liver disease.

Published in:

Hepatology Research, 2024, v. 54, n. 7, p. 655, doi. 10.1111/hepr.14020

By:

Nakano, Masahito;
Kawaguchi, Machiko;
Kawaguchi, Takumi;
Yoshiji, Hitoshi

Publication type:

Article

A comparative study of hepatic steatosis using two different qualitative ultrasound techniques measured based on magnetic resonance imaging‐derived proton density fat fraction.

Published in:

Hepatology Research, 2024, v. 54, n. 7, p. 638, doi. 10.1111/hepr.14019

By:

Ogawa, Sadanobu;
Kumada, Takashi;
Gotoh, Tatsuya;
Niwa, Fumihiko;
Toyoda, Hidenori;
Tanaka, Junko;
Shimizu, Masahito

Publication type:

Article

Safety and effectiveness of SARS‐CoV‐2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire‐based, cross‐sectional study.

Published in:

Hepatology Research, 2024, v. 54, n. 7, p. 706, doi. 10.1111/hepr.14018

By:

Tanifuji, Ayaka;
Ohfuji, Satoko;
Matsumoto, Kosuke;
Abe, Masanori;
Komori, Atsumasa;
Takahashi, Atsushi;
Kawata, Kazuhito;
Sato, Ken;
Joshita, Satoru;
Umemura, Takeji;
Ueno, Masayuki;
Nakayama, Nobuaki;
Kakisaka, Keisuke;
Arinaga‐Hino, Teruko;
Ito, Koichi;
Kanai, Sachiko;
Miura, Ryo;
Arizumi, Toshihiko;
Asaoka, Yoshinari;
Ito, Takanori

Publication type:

Article

Validation of Japanese indication criteria for deceased donor liver transplantation for hepatocellular carcinoma: Analysis of US national registry data.

Published in:

Hepatology Research, 2024, v. 54, n. 7, p. 695, doi. 10.1111/hepr.14017

By:

Bekki, Yuki;
Itoh, Shinji;
Toshima, Takeo;
Shimokawa, Mototsugu;
Yoshizumi, Tomoharu

Publication type:

Article

Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy.

Published in:

Hepatology Research, 2024, v. 54, n. 7, p. 615, doi. 10.1111/hepr.14016

By:

Kozuka, Ritsuzo;
Enomoto, Masaru;
Yukawa‐Muto, Yoshimi;
Odagiri, Naoshi;
Kotani, Kohei;
Motoyama, Hiroyuki;
Kawamura, Etsushi;
Hagihara, Atsushi;
Fujii, Hideki;
Uchida‐Kobayashi, Sawako;
Kawada, Norifumi

Publication type:

Article

Impact of the COVID‐19 pandemic on the number and short‐term outcomes in hepatectomy for hepatocellular carcinoma: Results from the Japanese National Clinical Database, 2018–2021.

Published in:

Hepatology Research, 2024, v. 54, n. 7, p. 685, doi. 10.1111/hepr.14014

By:

Takemura, Yusuke;
Endo, Hideki;
Hibi, Taizo;
Nakano, Yutaka;
Seishima, Ryo;
Takeuchi, Masashi;
Yamamoto, Hiroyuki;
Maeda, Hiromichi;
Hanazaki, Kazuhiro;
Taketomi, Akinobu;
Kakeji, Yoshihiro;
Seto, Yasuyuki;
Ueno, Hideki;
Mori, Masaki;
Kitagawa, Yuko

Publication type:

Article

Exploratory prospective, randomized phase II study of neoadjuvant transcatheter arterial chemoembolization plus surgery versus surgery alone for large hepatocellular carcinoma (CSGO‐HBP‐005): Clinical Study Group of Osaka University, Hepato‐Biliary‐Pancreatic Group

Published in:

Hepatology Research, 2024, v. 54, n. 7, p. 667, doi. 10.1111/hepr.14013

By:

Kobayashi, Shogo;
Tomokuni, Akira;
Takeda, Yutaka;
Wada, Hiroshi;
Katsura, Yoshiteru;
Hashimoto, Kazuhiko;
Tomimaru, Yoshito;
Asaoka, Tadafumi;
Yamada, Terumasa;
Tsujie, Masanori;
Noda, Takehiro;
Morita, Satoshi;
Nagano, Hiroaki;
Mori, Masaki;
Doki, Yuichiro;
Eguchi, Hidetoshi

Publication type:

Article

Issue Information.

Published in:: Hepatology Research, 2024, v. 54, n. 7, p. 613, doi. 10.1111/hepr.13919
Publication type:: Article

Apparent diffusion coefficient in intrahepatic cholangiocarcinoma diffusion‐weighted magnetic resonance imaging noninvasively predicts Ki‐67 expression.

Published in:

Hepatology Research, 2024, v. 54, n. 7, p. 678, doi. 10.1111/hepr.14015

By:

Hokkoku, Daiki;
Sasaki, Kazuki;
Kobayashi, Shogo;
Iwagami, Yoshifumi;
Yamada, Daisaku;
Tomimaru, Yoshito;
Asaoka, Tadafumi;
Noda, Takehiro;
Takahashi, Hidenori;
Shimizu, Junzo;
Doki, Yuichiro;
Eguchi, Hidetoshi

Publication type:

Article